SC
AGN.PRA

Sculptor Capital’s Allergan plc AGN.PRA Stock Holding History

Sculptor Capital’s Portfolio AGN.PRA Stock Details AGN.PRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-172,527
Closed -$127M – 412
2017
Q3 		$127M Buy
172,527
+6,564
+4% +$5.45M 0.62% 40
2017
Q2 		$144M Buy
165,963
+102,585
+162% +$86M 0.76% 36
2017
Q1 		$53.7M Buy
+63,378
New +$52.5M 0.31% 70
2016
Q4 		– Sell
-38,500
Closed -$31.6M – 406
2016
Q3 		$31.6M Buy
+38,500
New +$33.3M 0.18% 85
2016
Q2 		– Sell
-67,176
Closed -$61.6M – 451
2016
Q1 		$61.6M Buy
67,176
+25,828
+62% +$24.7M 0.31% 80
2015
Q4 		$42.4M Buy
+41,348
New +$41.5M 0.23% 96

Other funds holding AGN.PRA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
Allianz Asset Management
Allianz Asset Management Munich, Germany $112B AUM 36.28% 1-Year Est. Return
WAM
Weiss Asset Management Boston, Massachusetts $9.54B AUM 55.06% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Calamos Advisors
Calamos Advisors Naperville, Illinois $30.1B AUM 30.03% 1-Year Est. Return
ES
Equitec Specialists Chicago, Illinois $708K AUM 25.27% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return

Sculptor Capital's AGN.PRA Position: Q4 2017 in Review

Sculptor Capital sold out of Allergan plc (AGN.PRA) in Q4 2017, closing a stake of 172,527 shares — an estimated $127M sold.

Sculptor Capital first reported a position in AGN.PRA in Q4 2015 and held it in 6 quarters. The position peaked at $144M in Q2 2017. 90 funds tracked by Wall St. Rank hold AGN.PRA as of Q4 2017.

  • Sculptor Capital reported no remaining Allergan plc position as of Q4 2017 after selling out during the quarter.
  • Sculptor Capital sold 172,527 Allergan plc shares in Q4 2017, an estimated $127M.
  • Sculptor Capital first reported a position in Allergan plc in Q4 2015 and held it in 6 quarters.
  • Sculptor Capital's Allergan plc position peaked at $144M in Q2 2017.
  • 90 funds tracked by Wall St. Rank held Allergan plc as of Q4 2017.

Based on Sculptor Capital's 13F filing for Q4 2017, filed 13 Feb 2018.